Brock Bakewell, MD
Ophthalmology · Tucson, AZNPI 1487791547
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Glaukos Corporation at 55.9% of the total. 2025 is the largest year on record at $7,427, 7.9 times the $939 reported in 2019. Among ophthalmology clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 156 payments — averaging $76.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$7K
- Johnson & Johnson Surgical Vision, Inc.$2K
- Rxsight Inc$786
- Novartis$704
- Alcon$441
- AbbVie$280
- plus $2K from 17 others
Across 2 payments — averaging $6248.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bausch & Lomb Americas Inc.$12K
What the payments were for
- Consulting fees$5,20044%
- Speaking & faculty fees$390%
- Travel & lodging$5775%
- Food & beverage$6,05151%
- Education$851%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 13 | $6,680 |
| Johnson & Johnson Surgical Vision, Inc. | 43 | $1,508 |
| Rxsight Inc | 10 | $786 |
| Novartis | 35 | $704 |
| Alcon | 7 | $441 |
| AbbVie(2 entities) | 9 | $280 |
| Bausch & Lomb Americas Inc. | 5 | $184 |
| Mallinckrodt Hospital Products Inc. | 2 | $168 |
| Sight Sciences, Inc. | 2 | $160 |
| Aerie Pharmaceuticals, Inc. | 3 | $155 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $142 |
| Ocular Therapeutix, Inc. | 2 | $136 |
| Carl Zeiss Meditec, Inc. | 2 | $131 |
| Johnson & Johnson Vision Care, Inc. | 1 | $91 |
| Eyevance Pharmaceuticals LLC | 6 | $90 |
| Ivantis, Inc | 2 | $76 |
| Kala Pharmaceuticals, Inc. | 3 | $62 |
| Sun Pharmaceutical Industries Inc. | 2 | $45 |
| Amgen | 2 | $41 |
| Harrow Eye, LLC | 1 | $23 |
| Oyster Point Pharma, Inc. | 1 | $20 |
| ABB Con-cise Optical Group LLC | 1 | $15 |
| Shire North American Group Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Travoprost Intraocular Implant - iDose$6,035
- RXSIGHT CONTACT LENS$403
- RXSIGHT INJECTOR CARTRIDGE$403
- RXSIGHT INJECTOR HANDPIECE$403
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$403
- VERITAS Vision System$368
- LIGHT ADJUSTABLE LENS (LAL)$282
- Rhopressa$243
- Rocklatan$243
- iDose$182
- ACTHAR$146
- Tecnis IOL$137
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)$134
- iStent inject Trabecular Micro-Bypass Stent System$130
- DEXTENZA$125
- RXSIGHT LIGHT ADJUSTABLE LENS (RXLAL)$121
- TRAVATAN Z$120
- IOLMaster 500$115
- DURYSTA$115
- BEOVU$114
How this compares
$11,952 in reported general payments places this provider in the 90th percentile of 310 ophthalmology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 13 | $23,024 |
| LumiganBimatoprost | 41 | $19,577 |
| Prednisolone Acetate | 109 | $3,768 |
| Latanoprost | 306 | $2,753 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 22 | $2,058 |
| Fluorometholone | 12 | $807 |
| Acetazolamide | 13 | $626 |
| Timolol Maleate | 68 | $598 |
| MoxifloxacinMoxifloxacin Hcl | 19 | $372 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 23 | $330 |
| Brimonidine Tartrate | 17 | $109 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $34 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan | $280 | $42,60154 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 310 ophthalmology providers in Arizona.
Other ophthalmology in Tucson
- Martin WorrallTucson$12K
- Sean GarrityTucson$11K
- Andreas GonzalezTucson$11K
- Lynn PolonskiTucson$9K
- Joseph JulianoTucson$9K
- Ajay SananTucson$8K
- Michael DiesenhouseTucson$7K
- Ovette VillavicencioTucson$6K
- Rachel HuynhTucson$6K
- Patrick TsaiTucson$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.